http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007142581-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfc7c7b5f78df1b8d407606da4310e4c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f73a2927fb1a19dc670f834257e61346 |
| publicationDate | 2007-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2007142581-A1 |
| titleOfInvention | Combination product for the treatment or prevention of dyslipidaemia |
| abstract | A combination therapeutic product which comprises rosuvastatin calcium and a compound of formula I: [Chemical formula should be inserted here. Please see paper copy] The combinations of the invention are useful in a method for the treatment or prevention of dyslipidaemia, and/or in a method for the treatment or prevention of atherosclerosis, and/or in a method for the treatment or prevention of adverse cardiovascular complications associated with atherosclerosis (e.g. hypertension, angina pectoris, myocardial infarction, stroke (including cerebro vascular accident and transient ischaemic attack) and peripheral arterial occlusive disease). The invention also relates to a pharmaceutical composition comprising such combinations and to the use thereof in the manufacture of a medicament for use in the treatment of dyslipidaemia, or in the manufacture of a medicament for use in the treatment or prevention of atherosclerosis, or in the manufacture of a medicament for the treatment or prevention of adverse cardiovascular complications associated with atherosclerosis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019149091-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649220-B2 |
| priorityDate | 2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.